Skip to content
lifestyle.ideawins.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
May 28, 2026
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
May 22, 2026
Press Release: Belén Garijo to become Chief Executive Officer of Sanofi
February 12, 2026
Press Release: Sanofi completes the acquisition of Dynavax
February 12, 2026
←
Previous Page
1
2
3